Ovarian cancer is one of the leading causes of female cancer deaths in the most developed countries. The reason may lie in absence of early...
Molecular analysis of prognostically significant markers of chronic lymphocytic leukemia
Mgr. Erika Tomková, RNDr. Miroslav Tomka, PhD., RNDr. Renáta Lukačková, Mgr. Jakub Petrík
Chronic lymphocytic leukemia (CLL) is a clinically and biologically substantially heterogenous disease. In general, patients are classified into two groups: patients with indolent disease form...
Breast cancer encompasses heterogeneous group of tumors with different histological, biological and clinical behavior. Intra- and inter-tumor heterogeneity as a result of genetic and non-genetic...
Traditional cytogenetic methods like banding or fluorescent in-situ hybridization have found a stable place in screening for genetic abnormalities as well as in evaluation of...